Home > Products > hACE2-rAAV

hACE2-rAAV

Traditional Knock-In animal model construction usually takes at least 6 months and a lot of manpower. Obtaining large-scale animal models in a shorter period of time, especially in response to sudden drug development, have always been a great challenge. Whether a suitable animal model can be quickly obtained in time, is the key to success. To Face the challenge of the new coronavirus epidemic, PackGene has successfully developed a simple method to build an animal model to overexpress hACE2 protein. Our animal model shows a good tissue-specific distribution of hACE2, which is very suitable for new coronavirus-related drug development and research experiments.

PackGene finished products – quick delivery for your research.   Order product now.

PackGene applies the rAAV virus vector to infect specific mice organs so as to obtain the AAV-hACE2 animal model. The tissues in mice can continuously and stably express hACE2 protein, which is a simple and time-saving operation for new coronavirus-related drug development and research.

Comparison between AAV-hACE2 animal modeling and traditional animal modeling

AAV-hACE2 animal modeling
Traditional animal modeling

Production Cycle

Short cycle within 14 days
Over 6 months

Process

Simple
Complicated steps

Histotropism

Specific distribution
Wide distribution

Product Ordering

SKU Product Description Price Lead Time Quantity Action
hACE2-AAV AAV9[ssAAV.CAG.human ACE2.WPRE.SV40pA], ≥1E+13GC/ml, 100ul*10tube $2,599.00